Literature DB >> 7959762

Mapping of CD24 and homologous sequences to multiple chromosomal loci.

M R Hough1, P M Rosten, T L Sexton, R Kay, R K Humphries.   

Abstract

The human cell surface antigen, CD24, is a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that has been implicated in the differentiation and activation of granulocytes and B lymphocytes. Changes in expression of the antigen occur at critical times during B lineage development. CD24 was cloned by its homology to mouse heat-stable antigen. Southern blot analysis suggested the presence of multiple CD24 related sequences in the human genome. We have now mapped CD24 homologous sequences to chromosomes 6q21, 15q21-q22, and Yq11 by screening a panel of somatic cell hybrid DNAs and by in situ hybridization. At least two additional homologues, one located on chromosome 1 at band p36 and one tentatively mapped to chromosome 20, that are distantly related to CD24 were identified. Southern analysis of male and female DNA samples confirmed the presence of CD24 homologous sequences on the human Y chromosome. Sequencing of DNA fragments amplified from monochromosomal somatic cell hybrids showed that the CD24 cDNA was derived from a transcript originating from a gene on chromosome 6. The CD24 gene on the Y chromosome had many base changes compared to the cDNA but had retained an open reading frame, leaving open the question of whether this gene is functional. Both ATGs in the translation initiation region of CD24 homologous sequences on chromosome 15 were converted to GTGs, making it unlikely that this gene, if functional, encodes a protein similar to CD24. CD24, therefore, is a member of a multigene family, but it remains to be determined whether any of the related genes are functional.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959762     DOI: 10.1006/geno.1994.1356

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

Review 1.  Adipose tissue stem cells meet preadipocyte commitment: going back to the future.

Authors:  William P Cawthorn; Erica L Scheller; Ormond A MacDougald
Journal:  J Lipid Res       Date:  2011-12-02       Impact factor: 5.922

2.  Sox9 expression marks a subset of CD24-expressing small intestine epithelial stem cells that form organoids in vitro.

Authors:  Adam D Gracz; Sendhilnathan Ramalingam; Scott T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-25       Impact factor: 4.052

3.  The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Aliki Fiska; Michael I Koukourakis
Journal:  Med Oncol       Date:  2010-04-20       Impact factor: 3.064

Review 4.  CD24: from A to Z.

Authors:  Xianfeng Fang; Pan Zheng; Jie Tang; Yang Liu
Journal:  Cell Mol Immunol       Date:  2010-02-15       Impact factor: 11.530

5.  CD44 positive/CD24 negative (stem cell like property) breast carcinoma cells as marker of tumor aggression.

Authors:  Arijit Sen; B S Sunita
Journal:  Med J Armed Forces India       Date:  2016-04-16

6.  Epithelial Ovarian Cancer and Cancer Stem Cells.

Authors:  Amr A Soliman; Alaa A Elzarkaa; Eduard Malik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Elevated hippocampal CD24 in astrocytes participates in neural regeneration possibly via activating SHP2/ERK pathway after experimental traumatic brain injury in mice.

Authors:  Xuan Gao; Han Wang; Yong-Yue Gao; Xiao-Ming Zhou; Tao Tao; Guang-Jie Liu; Yan Zhou; Wei Li; Chun-Hua Hang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

8.  CD24 is a genetic modifier for risk and progression of prostate cancer.

Authors:  Yifan Zhang; Bingjin Li; Xingyi Zhang; Guru P Sonpavde; Kenneth Jiao; Andrea Zhang; Guangxin Zhang; Mei Sun; Chengjing Chu; Feng Li; Lizhong Wang; Ranji Cui; Runhua Liu
Journal:  Mol Carcinog       Date:  2016-07-19       Impact factor: 4.784

9.  Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.

Authors:  M I Koukourakis; A Giatromanolaki; V Tsakmaki; V Danielidis; E Sivridis
Journal:  Br J Cancer       Date:  2012-02-14       Impact factor: 7.640

10.  Implication of stem cells in the biology and therapy of head and neck cancer.

Authors:  Barbara Wollenberg
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.